Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third International CNS Germ Cell Tumor Study Group Protocol
NCT00025324Phase 2Unknown
- Sponsor
- Children's Hospital Los Angeles
- Start
- Dec 2000
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 3
01
Overview
A Phase 2 trial of carboplatin, etoposide, cyclophosphamide, thiotepa, filgrastim in central nervous system germ cell tumor, sponsored by Children's Hospital Los Angeles. Status: unknown.
02
Drugs
carboplatinetoposidecyclophosphamidethiotepafilgrastim
03
Conditions
central nervous system germ cell tumor
Beyond the preview
Go deeper on NCT00025324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025324.